Health Care Equipment & Services

Insider buying surge at Sophia Genetics signals confidence in its SaaS genomics platform; investors weigh upside amid valuation risks and regulatory hurdles.

Explore how CFO Crawford Amanda’s recent insider trades reveal her confidence in Owlet Inc., align with new leadership, and signal modest stake growth amid valuation challenges.

CEO Jamie Reynoso’s modest sale of 6,197 Clover Health shares is a routine, tax‑related move that won’t impact the stock or governance—yet it highlights how insider trading, research findings and regulatory changes shape the company’s Medicare Advan…

Insider buying shows Spectral AI’s confidence amid volatile valuation.

NeuroOne Medical’s insider buying shows executives bet on its quantum‑computing pivot—4% of shares now held, 95% YTD gain, but investors should weigh risk factors and liquidity concerns.

Insider buys at Nano‑X Imaging signal confidence in its AI‑powered imaging platform; watch Q4 earnings for proof of a turnaround.

Insider option exercise by 20‑20 Biolabs’ CFO signals confidence in its AI‑powered blood‑test platform and may boost investor trust ahead of regulatory milestones.

Kurzius Lawrence Erik’s April 1 insider trades show steady long‑term confidence in Cooper Cos’s contact‑lens and AI‑diagnostic growth, hinting at a potential rebound amid healthcare‑tech optimism.

Penumbra insider sale: director Harpreet Grewal sold 100 shares at $328.22 on Apr 2, 2026—small, routine trading that signals portfolio rebalancing, not a strategic shift.

BD insider sale shows routine liquidity, not confidence loss.